Question 1

What is Belsomra?

Accepted Answer

Belsomra is a medication that contains the active ingredient suvorexant and belongs to a class of drugs known as orexin receptor antagonists. Unlike some other sleep medications, it works by targeting the brain's wake-promoting system.

The drug functions by blocking the signals of orexin, a natural chemical in the brain that helps people stay awake. By inhibiting these signals, the medication helps support the body's ability to transition into sleep.

Question 2

What is Belsomra used for?

Accepted Answer

Belsomra is used to treat insomnia .

Question 3

How does Belsomra work?

Accepted Answer

How Belsomra Affects the Brain

Belsomra is classified as an orexin receptor antagonist. It works differently than many traditional sleep aids by targeting the brain's wake-promoting system rather than simply acting as a general sedative.

The brain naturally produces chemicals called orexins, which are responsible for keeping you alert and awake. Belsomra attaches to the receptors for these chemicals and blocks their activity. By quieting the signals that keep you awake, the medication helps to:

Decrease the time it takes to fall asleep.

Minimize nighttime awakenings.

Increase the total duration of sleep.

While the exact way it improves sleep is attributed to this blocking of orexin receptors, it is designed to specifically interfere with the chemical signals that maintain wakefulness.

Question 4

What are the active ingredients in Belsomra?

Accepted Answer

The active ingredient in Belsomra is suvorexant .

Question 5

What are the side effects of Belsomra?

Accepted Answer

Common side effects of Belsomra may include:

drowsiness

headache

dizziness

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Belsomra?

Accepted Answer

Belsomra belongs to the orexin receptor antagonist drug class.

Question 7

What is the dosage of Belsomra and how do I take it?

Accepted Answer

How to Take Belsomra

Belsomra is a tablet taken by mouth. For the best results, follow these administration guidelines:

Take the medication only once per night.

Swallow the tablet whole. Do not crush, chew, or break it.

Take your dose shortly before going to bed.

Only take Belsomra if you are able to stay in bed for a full night before you must be active again.

You may take the tablet with or without food. Taking it with or immediately after a meal may delay how quickly the medication starts to work.

Missed Dose

If you miss a dose, skip it if you do not have enough time for a full night of sleep. Do not take an extra dose to make up for a missed one. Resume your normal schedule the following night.

Question 8

Is Belsomra safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies of Belsomra in pregnant women to determine drug-associated risks. In animal studies, no evidence of structural abnormalities was found even at high doses. However, some instances of decreased fetal body weight were noted in animal models when the medication was administered at doses that also caused toxicity in the mother.

Patients who are pregnant or planning to become pregnant are encouraged to discuss the potential risks and benefits of this medication with their healthcare provider. If a patient becomes pregnant while taking Belsomra, they should notify their doctor.

Breastfeeding

It is not known if Belsomra is excreted in human breast milk. Data from animal studies indicate that the drug is present in the milk of lactating rats. Because many medications can pass into breast milk, the potential for adverse effects on a nursing infant is not fully understood.

The decision to use Belsomra while breastfeeding involves weighing several factors:

The clinical necessity of the medication for the mother.

The developmental and health benefits of breastfeeding for the infant.

The potential for side effects in the breastfed child from the medication or from the mother's underlying condition.

Question 9

What forms and strengths does Belsomra come in?

Accepted Answer

Belsomra is supplied as a film-coated tablet. This medication is intended for oral use and is typically taken once per night shortly before sleep.

Question 10

What is the FDA approval status of Belsomra?

Accepted Answer

FDA Approval and Indications

Belsomra (suvorexant) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of insomnia. It is specifically indicated for adults who experience difficulty with sleep onset (falling asleep) and sleep maintenance (staying asleep).

Controlled Substance Status

Belsomra is regulated as a Schedule IV controlled substance under the Controlled Substances Act. This classification indicates that while the drug has an accepted medical use, it also carries a risk for misuse, abuse, and the development of physical or psychological dependence. Healthcare providers are advised to evaluate the risk of abuse before prescribing and to monitor patients for signs of misuse during treatment.

Safety Warnings and Regulatory Communications

The FDA requires warnings on the labeling of Belsomra regarding the risk of complex sleep behaviors. These behaviors occur when a person is not fully awake and may include:

Sleepwalking

Sleep-driving

Preparing and eating food

Making phone calls

Because these activities can lead to serious injuries or death, the FDA recommends that the medication be discontinued immediately if a patient experiences any complex sleep behavior. Unlike certain other insomnia medications, Belsomra is an orexin receptor antagonist and was not included in the specific 2019 Boxed Warning mandate that applied to sedative-hypnotics like zolpidem, though it carries similar warnings in its prescribing information.

Additionally, the FDA has issued safety communications regarding the risks of combining sleep medications with other central nervous system (CNS) depressants. Using Belsomra in combination with alcohol or opioid pain medications can lead to profound sedation, respiratory distress, coma, or death.

Question 11

What should I know about Belsomra and insomnia?

Accepted Answer

How Belsomra Works for Insomnia

Belsomra (suvorexant) is an orexin receptor antagonist. It works by blocking the action of orexin, a chemical in the brain that helps keep you awake. By decreasing these wake-promoting signals, Belsomra helps patients transition into sleep and maintain sleep throughout the night.

The medication is approved for the treatment of insomnia characterized by:

Sleep onset: Difficulty falling asleep at the beginning of the night.

Sleep maintenance: Difficulty staying asleep or waking up too early and being unable to return to sleep.

Dosing and Administration

For the treatment of insomnia, Belsomra should be taken once per night, within 30 minutes of going to bed. It is important to ensure that at least 7 hours are available for sleep before you need to be active again. Taking the medication with or immediately after a meal may delay the time it takes to work.

If sleep problems persist or worsen after 7 to 10 days of treatment, it may indicate the presence of a primary medical or psychiatric condition that requires further evaluation by a healthcare professional.

Belsomra

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Insomnia Information

FAQ

Additional Resources

Support & Help Resources

Found an Error?